Knee cartilage repair for teens: study pulled before it began
NCT ID NCT05391841
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study planned to test NOVOCART Inject, a treatment using a patient's own cartilage cells, for repairing knee cartilage defects in teenagers whose bones had finished growing. The goal was to see if it improved knee function and pain. However, the study was withdrawn before enrolling any participants, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NOVOCART Inject (a treatment using the patient's own cartilage cells to repair knee damage)
- What this could lead to
- If it had worked, this could have pointed toward a way to repair knee cartilage in teenagers, potentially delaying or avoiding knee replacement later in life.
- What could go wrong
- The study was withdrawn before any patients were enrolled, so no results are available. Even if it had proceeded, it was a small, single-arm study with no comparison group, making it hard to know if the treatment truly helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARTILAGE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Klinikum rechts der Isar, Technische Universität München
München, 81675, Germany
-
OCM Klinik GmbH München
München, 81369, Germany
-
St. Josefs-Hospital Cloppenburg gemeinnützige GmbH
Cloppenburg, 49661, Germany
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79119, Germany
-
Universitätsklinikum Regensburg
Regensburg, 93053, Germany
-
Universitätsklinikum Tübingen
Tübingen, 72076, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.